The region of conserved synteny on mouse chromosome 11/human 17q11-q21 is known to carry a susceptibility gene(s) for intramacrophage pathogens. The region is rich in candidates including NOS2A, CCL2/MCP-1, CCL3/MIP-1a, CCL4/MIP-1b, CCL5/RANTES, CCR7, STAT3 and STAT5A/5B. To examine the region in man, we studied 92 multicase tuberculosis (627 individuals) and 72 multicase leprosy (372 individuals) families from Brazil. Multipoint nonparametric analysis (ALLEGRO) using 16 microsatellites shows two peaks of linkage for leprosy at D17S250 (Z lr score 2.34; P¼0.01) and D17S1795 (Z lr 2.67; P¼0.004) and a single peak for tuberculosis at D17S250 (Z lr 2.04; P¼0.02). Combined analysis shows significant linkage (peak Z lr 3.38) at D17S250, equivalent to an allele sharing LOD score 2.48 (P¼0.0004). To determine whether one or multiple genes contribute, 49 informative single nucleotide polymorphisms were typed in candidate genes. Family-based allelic association testing that was robust to family clustering demonstrated significant associations with tuberculosis susceptibility at four loci separated by intervals (NOS2A-8.4 Mb-CCL18-32.3 kb-CCL4-6.04 Mb-STAT5B) up to several Mb. Stepwise conditional logistic regression analysis using a case/pseudo-control data set showed that the four genes contributed separate main effects, consistent with a cluster of susceptibility genes across 17q11.2.
Introduction
Many studies support the hypothesis that susceptibility to Mycobacterium tuberculosis and M. leprae is genetically regulated in humans.
1,2 One approach to identifying candidate genes is to study genetic susceptibility in mice and examine the regions of conserved synteny in man. We took this approach to analyse susceptibility to leishmanial infections. 3, 4 This led to identification of a region on mouse chromosome 11, syntenic with human chromosome 17q11.1-q12, which carries susceptibility genes to cutaneous leishmaniasis. 5, 6 This region is rich in candidate susceptibility genes. These include the gene (NOS2A) encoding the inducible form of nitric oxide synthase (iNOS), genes encoding members of the family of small inducible chemokine gene (designated, for example, chemokine, CC motif, ligand 1 or CCL1) cluster (eg CCL2/SCYA2/MCP-1, CCL3/SCYA3/MIP-1a, CCL4/ SCYA4/MIP-1b, CCL5/SCYA5/RANTES), the gene (CCR7) encoding the receptor for CCL19/CCL21 and genes for signal transducers and activators of transcription STAT3, STAT5A and STAT5B.
The shared intramacrophage niche of leishmanial and mycobacterial (M. tuberculosis and M. leprae) pathogens, and the similar spectra of disease caused by the two groups of organisms, means that any gene identified as a susceptibility gene for one group of pathogens becomes a candidate for the others. A well-characterized example of this is the gene (Nramp1/NRAMP1) located on mouse chromosome 1/human 2q35 that encodes the natural resistance associated macrophage protein 1, now redesignated as solute carrier family 11a member 1 (Slc11a1 in mice; SLC11A1 in man). This gene controls innate resistance to Leishmania donovani, 7-10 M. bovis BCG, 11 M. lepraemurium 12, 13 and M. intracellulare 14 in the mouse, and contributes to susceptibility to M. tuberculosis, [15] [16] [17] [18] [19] [20] [21] [22] M. leprae 23 and L. donovani 24, 25 in man. The successful mouse-to-man precedent set with Slc11a1/SLC11A1 encouraged us to take a similar approach in studying the region of human chromosome 17q syntenic with murine chromosome 11 in relation to genetic susceptibility to leprosy and tuberculosis in man. Here we present linkage and allelic association data for polymorphic loci at 17q11-q21 from 92 multicase families of tuberculosis and 72 multicase families of leprosy from Belem, Brazil that support the hypothesis that a cluster of genes in this region regulate mycobacterial infections in man.
Results
Genetic and physical maps for chromosome 17q11.1-q21. 31 A total of 627 individuals from 98 multicase tuberculosis families and 372 individuals from 72 multicase leprosy families (Table 1) were initially genotyped for 16 microsatellite markers across the chromosome 17q11.1-q21.31 region. Marker-marker linkage data from the combined set of families were used to generate a genetic map ( Figure 1 ) using CRI-Map 26 and MAP-O-MAT. 27 This is compared ( Figure 1 ) to the current physical map order for the same markers obtained from the UCSC Human Genome Project Working Draft, November 2002 freeze (NCBI Build 31) . The only inconsistency between the genetic and physical map order is for the marker D17S2015. This discrepancy in position could be due either to assembly errors in the physical map or to a lack of informative meioses in the genetic mapping. Since the genetic map provides a more accurate representation of recombination events across the region, we used the genetic map generated from the Brazilian families in multipoint linkage analyses presented below.
Linking disease susceptibility to chromosome 17
Results of multipoint nonparametric linkage analyses carried out in ALLEGRO are presented in Figure 2 . For leprosy per se, a broad region of linkage was observed, with an initial peak (Z lr 2.34; P¼0.01) at D17S250 and a second peak (Z lr 2.67; P¼0.004) at D17S1795. For tuberculosis, a single peak (Z lr 2.04; P¼0.02) suggestive of linkage was observed at D17S250, with no linkage at D17S1795. Analysis by disease subtype (Figure 2) shows that all of the linkage to leprosy at the D17S250 peak is contributed by the TT leprosy families (Z lr 2.58; P¼0.005), whereas LL families appear to make some contribution to the leprosy per se peak at D17S1975. Combined linkage analysis for all leprosy and tuberculosis families gave a peak multipoint Z lr ¼3. Family-based transmission disequilibrium testing (TDT) To determine whether one or multiple candidate genes might contribute to mycobacterial disease susceptibility NOS2A  TNFAIP1  CRLF3   CSF3   CCR7   THRA1   STAT5A & 5B  STAT3   CCL2  CCL7  CCL11  CCL8  CCL13  CCL1   CCL14   CCL16   CCL5   MMP28   CCL15  CCL23  CCL18  CCL3 on 17q11.2, an additional 69 single nucleotide polymorphisms (SNPs) were typed in candidate genes. These included 10 novel SNPs in the promoter of NOS2A and, where possible, at least two SNPs (except STAT5B and CCR7 where only one SNP was available) in each of the candidates (in order across the region)  TNFAIP1, CRLF3, CCL2,11,8,13,1,5,16,15,14,23, 18,3,4,  CSF3 , THRA, CCR7, STAT5A, STAT5B and STAT3. Details of the SNPs, including primer sequences, nucleotide transitions and allele frequencies, appear in Web- Tables 8 and 9 . Of these SNPs, 49 were informative (variant allele frequency X0.1) for allelic association testing in the tuberculosis families. Analysis of these data using TDT 28 with a robust sandwich estimator for the variance and a Wald w 2 test to allow for family clustering provides evidence for four regions contributing to susceptibility to tuberculosis (Table 2) . From proximal to distal 17q11.2, these were as follows: CCL18, CCL4 and STAT5B all fall under Pp0.05 area of the first linkage peak on 17q11.2. NOS2A lies immediately proximal to the first linkage peak (Figure 2 ), but outside the Pp0.05 area of linkage. No other significant allelic associations were observed for candidate genes under this linkage peak for tuberculosis.
Case/pseudo-control single marker and intralocus stepwise logistic regression analyses Family-based allelic association testing using TDT that was robust to pedigree clustering suggested that polymorphism at multiple candidate genes might contribute to the disease associations with tuberculosis. SNPs at multiple candidate genes, some separated by intervals (NOS2A-8.4 Mb-CCL18-32.3 kb-CCL4-6.04 Mb-STAT5B) of several Mb, all indicated positive allelic associations. Conditional logistic regression analysis ( Table 3 ) that used a case/pseudo-control data set derived from the families and was robust to nuclear family clustering essentially confirmed the associations (cf below) observed using robust TDT. In comparing allele-wise and genotype-wise associations in the case/pseudo-control analysis, no dominance effects (defined as departure from the multiplicative model for the effects of alleles on the overall genotype relative risks) were observed at any of the candidate gene loci (data not shown). To determine Figure 2 Multipoint nonparametric Zlr scores for linkage between microsatellite markers across chromosome 17q11.2-q23.2 and susceptibility to tuberculosis, leprosy per se, leprosy LL vs TT subtypes, and for combined analysis for mycobacterial susceptibility genes controlling tuberculosis and leprosy per se or tuberculosis plus TT leprosy. Linkage scores are plotted as a function of marker location in centimorgans (cM) according to the genetic linkage map generated using data for all tuberculosis and leprosy families (see Figure 1 ). Graphs are annotated with approximate positions for candidate genes across the region. Dotted lines indicate the levels of significance associated with Z lr scores. : chi squared; df: degrees of freedom; P: probability. XuiNOS is a microsatellite, all other markers are SNPs. Bold indicates significant associations ( Pp0.05).
Genetic susceptibility to tuberculosis and leprosy SE Jamieson et al whether each of these loci contributed significant main effects to the chromosome 17q11.2 associations observed, we carried out tests to determine main effects at each locus in a forward stepwise logistic regression procedure. 29 To achieve this, we first carried out a forward stepwise logistic regression analysis for the multiple markers within each candidate gene locus to determine which markers contributed significant main effects. All comparisons used logistic regression analysis with robust variance estimates and a Wald w 2 test to allow for family clustering.
Case/pseudo-control analysis confirmed significant associations between tuberculosis and the SNP at position -1026 in the promoter of NOS2A (Table 3 ). The allele-wise relative risk associated with allele À1026G was 3.25 (95% CI 1.19-8.81; P¼0.021), that is, the common allele was disease associated. Since only one SNP showed significant association, no intralocus stepwise analysis was performed.
Case/pseudo-control analysis confirmed significant associations between tuberculosis and the SNPs rs2015086, rs2015070 and rs14304 at CCL18 (Table 3) . The allele-wise relative risk associated with allele rs2015086C was 0.41 (95% CI 0.24-0.71; P¼0.001), with allele rs2015070A was 0.35 (95% CI 0.18-0.68; P¼0.002) and with allele rs14304A was 0.38 (95% CI 0.19-0.75; P¼0.005), that is, the variant allele at each SNP was disease protective. SNPs rs2015086 and rs2015070 lie 166 bp apart in the 5 0 flanking region and intron 1 at the proximal end of CCL18 ( Figure 3 ). SNP rs14304 lies 6.7 kb distal to rs2015086 and rs2015070 in the 3 0 UTR at the distal end of CCL18. SNPs rs2015086 and rs2015070 are in strong linkage disequilibrium ( (Table 5 ) demonstrated that rs2015086 and rs2015070 did not add significant main effects to each other, but both had significant main effects when compared to rs14304 alone. Similarly, rs14304 adds significant main effects to both rs2015070 alone and rs2015086 alone, and the two together. This suggests that there are separate functional polymorphisms in linkage disequilibrium with the markers at the 5 0 and 3 0 ends of CCL18 that are contributing to disease association with tuberculosis.
Case/pseudo-control analysis confirmed significant associations between tuberculosis and the SNPs rs1634514 and rs1719144 at CCL4 (Table 3 ). The allelewise relative risks associated with allele rs1634514T (common allele) was 2.00 (95% CI 1.01-3.96; P¼0.047) and with allele rs1719144A (variant allele) was 0.35 (95% CI 0.18-0.68; P¼0.002). SNP rs1634514 lies in the 5 0 flanking region of CCL4 ( Figure 3 ). CCL4 rs1719144 lies in intron 1 485 bp distal to rs1634514. CCL4 rs1634514 and rs1719144 are in strong linkage disequilibrium (Table 4) with each other (D 0 ¼0.94). The stepwise analysis (Table 5) demonstrates that the associations at CCL4 rs1634514 and rs1719144 can each be accounted for by association at the other, that is, neither adds separate main effects to the other.
Case/pseudo-control analysis confirmed significant associations between tuberculosis and SNP rs2230097 at STAT5B (Table 3 ). The allele-wise relative risks associated with allele rs2230097C (variant allele) was 0.36 (95% CI 0.13-0.95; P¼0.038). Since only one SNP was available, no intralocus stepwise analysis was possible.
The only single marker association to remain significant after application of a strict Bonferroni correction 30 (multiplication by 49 informative SNP types) for multiple testing was CCL18 rs2015086 (Table 3) .
Linkage disequilibrium occurred between markers within the three regions (see Figure 1) carrying the four candidate genes (Tables 4 and 6 ), but no extended linkage disequilbrium was observed across the three regions (D 0 p0.5; data not shown). Interestingly, no associations were seen between tuberculosis and markers for candidate genes (CCL2, 11, 8, 13, 1) in the more proximal group of chemokine genes (see Figure 1 ). Intra- Genetic susceptibility to tuberculosis and leprosy SE Jamieson et al and interlocus linkage disequilibrium was observed for CCL2/11 and CCL13/1 within this group of markers (Table 6b) .
Case/pseudo-control interlocus stepwise logistic regression analyses To determine whether all four candidate genes for which significant associations had been observed contributed independent main effects to the association between 17q11.2 and tuberculosis, stepwise interlocus logistic regression analysis was performed (Table 7) . Since CCL18 rs2015086 and rs2015070 did not show separate main effects from each other, only the more significant CCL18 rs2015086 was used in the interlocus stepwise analysis. Similarly, since CCL4 1634514 and rs1719144 did not show separate main effects, only the more significant CCL4 rs1719144 was used in the interlocus stepwise analysis. All comparisons used logistic regression analysis with robust variance estimates and a Wald w 2 test to allow for family clustering. In all of these analyses, a significant Wald w 2 indicates that addition of the marker in bold under the alternative model adds a significant separate main effect to the marker considered under the null hypothesis. Table 7 demonstrates that the À1026 bp SNP in the promoter of NOS2A contributed separate main effects to all other markers for which significant associations were observed across 17q11.2. While there was strong linkage disequilibrium between markers in the NOS2A promoter (Table 6a) , there was no extended linkage disequilibrium with SNPs at candidate genes (TNFAIP1 and CRLF3) immediately distal to NOS2A (Table 6a) or any of the other markers across 17q11.2 (data not shown). Taken together, these data suggest that polymorphism at NOS2A itself is associated with susceptibility to tuberculosis in this population.
Similarly, the 5 0 SNP rs2015086 at CCL18 contributed separate main effects to all other markers for which significant associations were observed across the region ( Table 7 ), indicating that polymorphism at CCL18 may also contribute independently to susceptibility to tuberculosis in this population. Interestingly, SNP rs1719144 at CCL4 contributed separate main effects to rs2015086 but not rs14304 at CCL18. Similarly, SNP rs14304 at CCL18 contributed significant main effects when compared to rs2015086 at CCL18 (Table 5 ), but not when compared to SNP rs1719144 at CCL4. SNP rs1719144 lies in intron 1 of CCL4 32.756 kb distal to CCL18 rs14304 (Figure 3) , with CCL3 encoded within this interval. CCL4 rs1719144 is in strong linkage disequilibrium (Table 4) with the 3 0 CCL18 SNP rs14304 (D 0 ¼0.73), which explains why these two SNPs do not contribute separate main effects to each other. These results suggest that there may be more than one functional polymorphism across the region CCL18-CCL3-CCL4 that contribute separately to susceptibility to tuberculosis in this population, one in linkage disequilibrium with SNP rs2015086 at the 5 0 end of CCL18 and a second in linkage disequilibrium with SNPs across 3 0 CCL18-CCL3-CCL4. SNP rs2230097 in the 5 0 UTR of STAT5B, 6.04 Mb distal to CCL4, contributed significant main effects when compared to CCL4 rs1719144 but not to more proximal candidate genes at 17q11.2. STAT5B is not in significant linkage disequilibrium with markers at any of the proximal candidate genes for which significant associa- Table 4 Linkage disequilibrium (D Genetic susceptibility to tuberculosis and leprosy SE Jamieson et al Markers around (a) NOS2A, (b) the proximal chemokine gene cluster, and (c) STAT5B (see Figure 1 ). Bold indicates moderate to strong linkage disequilibrium (D 0 40.5).
Genetic susceptibility to tuberculosis and leprosy SE Jamieson et al tions were observed across 17q11.2 (data not shown). However, some extended linkage disequilibrium (Table  7c ) was observed between STAT5B and CSF3, and between CSF3 and CCR7. Although association between disease susceptibility and the particular SNPs examined at these candidate loci was not observed, it is possible that the association with STAT5B could result from linkage disequilibrium with a functional polymorphism at these adjacent candidate genes.
Discussion
A common theme emerging from studies of complex traits such as infectious and autoimmune diseases is that multiple genes frequently contribute to regions of linkage to disease susceptibility. In mice, this has been highlighted by analysis of congenic mouse strains where progressive refinement of the congenic interval has identified multiple genes contributing to a region of linkage. [31] [32] [33] [34] In humans this is more difficult to demonstrate as definitively as in the mouse, but the application of stepwise logistic regression procedures 29 provides a statistical approach that allows the relative contribution of candidate genes within a linked region to be determined from case-control or family data. This is particularly appropriate in the analysis of regions of the genome that contain clusters of immune response, such as HLA, chromosome 5q23-q33, and the region of chromosome 17q11-q21 that we have studied here. Linkage analysis performed here using 16 microsatellite markers provided evidence for linkage between this region and susceptibility to leprosy and tuberculosis.
Stepwise conditional logistic regression analysis using a case/pseudo-control data set derived from the larger set of tuberculosis families confirmed that at least four separate candidate genes, NOS2A, CCL18, CCL4 and STAT5B, or genes in linkage disequilibrium with them, may contribute to the region of linkage on 17q11.2. Robust tests that controlled for pedigree clustering confirmed allelic association in the presence of linkage. Although these results do not provide definitive evidence that these are the aetiological loci regulating disease susceptibility, some discussion of their likely candidacy in relation to recent genetic and functional studies is relevant.
The first gene contributing separate main effects to allelic associations across the region was NOS2A, which lies immediately proximal to the region of linkage at Po0.05 on chromosome 17q11.2. The SNPs used in this study were identified as part of an earlier infectious disease study in which a single haplotype, uniquely defined by the NOS2A-1659T allele, was associated with cerebral malaria in The Gambia. 35 In Brazil, no association with NOS2A-1659 was observed, even though all four promoter SNPs were in linkage disequilibrium with each other. Our sample size was not sufficient to undertake a detailed analysis of haplotypes associated with tuberculosis in this Brazilian population. From studies in Tanzania and Kenya, Hobbs et al 36 also identified a novel SNP, À1173C-T, associated with protection from symptomatic malaria and severe malarial anaemia. Functionally, NOS2A provides a credible candidate for tuberculosis susceptibility. Choi et al 37 examined resected lungs from eight tuberculosis patients for expression of iNOS and nitrotyrosine, a marker of nitric oxide production. Immunohistochemical analysis revealed that NOS2A was expressed in CD68-positive 38 suggesting that downregulation of nitric oxide production may be counterprotective. This is consistent with the demonstration that nitric oxide production correlates with inhibition of bacterial growth in alveolar macrophages in vitro. 39 Other work 40 has also demonstrated high and specific expression of iNOS in granulomas surrounding and infiltrating dermal nerves in borderline leprosy lesions, with and without reversal reaction, suggesting that regulation of iNOS expression might also be involved in leprosy susceptibility and/or in the nerve damage following reversal reaction in leprosy. Although our sample size for leprosy precluded confirmation of a role for polymorphism at NOS2A in contributing to susceptibility to leprosy in this population, further studies in Brazil to obtain larger samples are in progress.
The second region that contributed separate main effects to tuberculosis susceptibility contained genes encoding chemokines CCL18, CCL3 and CCL4. Strong linkage disequilibrium across the region encoding these three genes (Table 4 ) means that we cannot be certain as to which genes contain the functional polymorphisms influencing tuberculosis, although it seems likely that more than one candidate gene across the region may be involved. Some evidence for extended linkage disequilibrium to other chemokine genes (CCL16,15,23 but not CCL5 encoding RANTES, Table 4) in this cluster means that these may also be involved. Nevertheless, the stepwise logistic regression analysis suggested an independent role for polymorphism at the 5 0 and 3 0 ends of CCL18, the latter in linkage disequilibrium with SNPs in CCL4 also contributing separate main effects. CCL18 is a small inducible chemokine that was formerly known as pulmonary and activation-regulated chemokine or PARC. Northern blot analysis shows that PARC is expressed at high levels in lungs, and at lower levels in some lymphoid tissues, 41 making it an alluring candidate for a tuberculosis susceptibility gene. Independently, Adema et al 42 identified the PARC gene, which they called DCCK1, as a gene expressed in dendritic cells with high levels of expression dependent on the presence of interleukin 4. DCCK1 acted preferentially as a chemokine for naïve T cells, suggesting that it is important in the initiation of an immune response. Other workers 43 also identified DCCK1 as a chemokine induced in macrophages by alternative activation with interleukin 4 and glucocorticoids, a factor that could be important in the light of studies demonstrating that activation of the hypothalamus-pituitary-adrenal axis affects antimycobacterial activity of macrophages in vivo. 44, 45 CCL3 and CCL4 encode macrophage inflammatory proteins (MIP) MIP1a and MIP1b that act as chemoattractants for polymorphonuclear leucocytes and monocytes. Many studies have documented the importance of CC chemokines in lung pathology, 46 with MIP-1a and/or MIP-1b specifically identified as chemokines expressed in response to M. tuberculosis stimulation in macrophage cell lines 47 and alveolar macrophages. 48 In a recent study, Lande et al 49 also demonstrated that high levels of CCL3 and CCL4 were produced within 8 h after infection of dendritic cells with M. tuberculosis. Interestingly, their work also showed that maturing M. tuberculosis-infected dendritic cells express high levels of CCR7 and become responsive to its ligand CCL21. Linkage disequilibrium across the region means that we cannot preclude polymorphism at CCR7 as contributing to the fourth component of susceptibility to tuberculosis measured here using SNPs at STAT5B. Sallusto et al 50 demonstrated that expression of CCR7 divides human memory T cells into two functionally distinct subsets. CCR7-negative memory T cells display immediate effector function. CCR7-positive memory cells provide long-term central memory and efficiently stimulate dendritic cells and differentiate into CCR7-negative effector cells upon secondary stimulation. The work of Lande et al 49 highlights the complex interplay between chemokines and receptors that occurs with M. tuberculosis infection, which they postulate orchestrates the recruitment and selective homing of activated/effector cells known to accumulate at the site of M. tuberculosis infection and take part in the formation of the granulomas. It is possible that longrange regulatory elements on 17q11.2 could coordinate expression in response to infection and may contribute to the complex pattern of disease susceptibility genes and linkage disequilibrium observed across the region.
In our study we have accessed high-throughput genotyping technology that has allowed us to undertake an extensive analysis of SNPs across the region of chromosome 17q11.2. Since we used families with multiple cases, we were careful to employ tests for allelic association that were robust to pedigree clustering. While the robust stepwise conditional logistic regression analysis allowed us to demonstrate that different genes across the region contribute separate main effects, the ability to type many markers has provided an additional problem in deciding how to correct for multiple testing. The only single marker test statistic to remain significant after application of a strict Bonferroni correction 30 (ie multiplying by the number of informative SNPs typed across the region) was CCL18 rs2015086. The issue of appropriate correction for multiple testing is complex and one that has preoccupied statisticians in general 30, 51 and genetic statisticians in particular. In our case, application of a strict Bonferroni correction is overconservative, since we know that the 49 SNPs are not all independent of one another. A less conservative approach is to carry out permutation tests. We calculated permutation P-values for the case/pseudo-control single marker test statistics (data not shown) by carrying out 1000 replications randomly permuting the 'case' and 'control' labels within each set of case and pseudocontrols and repeating the regression analysis. However, we did not improve on a Bonferroni correction, possibly due to loss of power when generating a case/pseudocontrol data set as it was not always possible to infer phase in the parents when using all the markers at once. For this analysis, it was necessary to generate the case/ pseudo-control data set using all markers simultaneously to take into account linkage disequilibrium between markers for the permutation procedure. Our experience highlights important issues relating to sample size that need to be addressed in planning genetic studies of complex traits. When we collected our families in Brazil between 1991 and 1993, our efforts were focused on obtaining large multicase families that would be powerful for linkage analysis. With the development of familybased allelic association testing, a better strategy now is to collect a separate sample of case/parent trios to facilitate independent allelic association testing, and to ensure that this sample has sufficient power to detect small effect sizes (odds ratios) for variant alleles at low frequency and to correct for multiple testing. To plan our future studies, we calculated the theoretical power to detect allelic association with 200, 400, 600 and 800 case/ parent trios using the method of Knapp 52 and assuming a multiplicative model (see Supplementary Information- Table 10 ). To achieve P¼0.001 (to allow for correction for 50 markers typed) for odds ratios of the order of magnitude (o0.5 or 42.0) observed here for variant alleles at frequencies o0.2, we need a minimum of 200-400 case/parent trios. Interestingly, we would never gain 445% power to achieve P¼0.001 for an odds ratio o2 and a variant allele at frequency 0.1 even with 800 parent/child trios (¼2400 total samples). Hence, there has to be a balance between sample size and return for effort. New studies in Brazil designed to improve our power are underway, as are studies designed to replicate our observation for tuberculosis in other populations and to determine whether the same or different genes across this region regulate leprosy per se or LL and TT disease subtypes. For these, we have set a target of 400 case/ parent trios as a realistic compromise between sample availability and power to detect moderately strong associations.
Overall, our study follows the trend that clusters of genes under broad linkage peaks contribute to complex disease inheritance. Our results provide encouragement that continued investigation of this region of chromosome 17q11.2 may provide valuable insight into the genes and mechanisms that contribute to the variable disease and pathology associated with tuberculosis and leprosy in Brazil.
Study population and methods

Ascertainment of families
Leprosy and tuberculosis families were ascertained through medical records at local Ministerio de Sanidad health centres in Belem, Para, Brazil. Families were pursued when there was indication on the medical record that additional family members had been or were currently affected with leprosy or tuberculosis. All health centres were staffed by clinicians highly experienced in the diagnosis and treatment of leprosy and tuberculosis. The study was performed with the approval of the ethical review committee of the Institute Evandro Chagas, Belem, Para, Brazil.
For tuberculosis families, diagnosis was made on the basis of a sputum test positive for acid-fast bacilli and/or chest X-ray. Sputum tests were carried out at the centres, stained (Ziehl-Nielson) and read for acid-fast bacilli by qualified laboratory technicians. If tuberculosis symptoms persisted following two negative sputum results, patients were referred to the central tuberculosis hospital in Belem, where all X-rays were read by experienced specialist clinicians. Cases of pulmonary tuberculosis only were included in this study. Other clinical forms of tuberculosis were at too low a frequency to permit genetic analysis of multicase pedigrees. Families came from an area of high tuberculosis prevalence. The incidence rate for tuberculosis in Belem City at the beginning (1991) of the study was 62 per 100 000 habitants. The prevalence rate for tuberculosis in the whole of Brazil is 68 cases per 100 000 habitants (Electronic Database Information 1).
Leprosy diagnosis was made following clinical examination for anaesthetic skin lesions, results from slit skin smear testing for acid-fast bacilli, and, in some health centres, histological analysis. Patients were categorized into disease subtype groups according to the Ridley-Jopling histological scale 53 and/or bacterial load. Subtypes recorded were lepromatous (LL), borderline lepromatous (BL), borderline (BB) or borderline tuberculoid/tuberculoid (BT/TT). For genetic analyses in the present study, lepromatous patients comprised LL plus BL subtypes (referred to hereafter as LL) and tuberculoid patients comprised BB plus BT/TT subtypes (referred to hereafter as TT). The incidence rate for leprosy in Belem City at the beginning of the study was 45 per 100 000 population. The prevalence rate for leprosy in the whole of Brazil is 45 cases per 100 000 habitants (Electronic Database Information 2).
All families were of equivalent socioeconomic status. Attempts to determine BCG vaccination status on all members of the pedigrees were either incomplete (as determined by vaccine records) or inconclusive (as determined by recording of scar status at interview), and were not included in the analyses. Blood was collected by venepuncture for all available members of the families. Epstein-Barr virus (EBV)-transformed B cells were prepared and cryopreserved for transport to UK. In Cambridge, EBV cells were expanded and DNA prepared for genetic analysis. A total of 92 multicase families (627 individuals) for tuberculosis and 72 multicase families (372 individuals) for leprosy were available for analysis after checking for genetic integrity within all families. Table 1 provides a breakdown of the family structures for each disease.
Genotyping
A total of 16 microsatellite markers spanning the candidate region were used in the analysis, 14 chosen from the Genetic Location Database maintained by the Human Genetics Division of the University of Southampton (Electronic Database Information 3), a microsatellite designated here as XuINOS within the NOS2A promoter, 54 and D17S250. 55 Primer sequences were obtained from the relevant publications 54, 55 or from the Whitehead Institute (Electronic Database Information 4). Fluorescently tagged primer pairs were ordered from PE Applied Biosystems (Warrington, UK) or Invitrogen (Paisley, UK). All microsatellites were analysed by electrophoresis on 6% polyacrylamide gels using an automated sequencer (model ABI-Prism 377, PE Applied Biosystems) and data collected and analysed using GENESCANt and GENOTYPERt software (PE Applied Biosystems).
A 59 High-throughput genotyping was performed using uniplex or biplex Invader assays (Third Wave Technologies, Madison, WI, USA) or TaqMan Assay-by-Design (PE Applied Biosystems), apart from three SNPs where the introduction/ abolition of a restriction fragment length polymorphism recognition site was used. All fluorescent assays were performed in 384-well plates and were set up using a BiomekFX robotics system (Beckman, High Wycombe, UK). Following incubation, Invader assays were analysed using a Wallac Victor 2 (PE Applied Biosystems) fluorescence plate reader and TaqMan assays analysed using an ABI Prism 7900HT Sequence Detecetion System (PE Applied Biosystems). Invader and TaqMan assays were analysed for genotype clustering using locally available software. Full details of primer sequences and assays are available (see Supplementary Information- Table 8 ).
Marker allele frequencies were determined from unrelated individuals in the families using the computer programme SPLINK. 
Linkage analysis
Multipoint nonparametric linkage analysis was performed in ALLEGRO 61 using the Spairs scoring function and the exponential allele-sharing model 62 with all families weighted equally. ALLEGRO reports allele sharing LOD scores and maximum Z scores for the likelihood ratio (Z lr ). One-sided P-values associated with LOD and Z lr scores are used throughout. For multipoint analysis, genetic distances between markers were entered in cM from the genetic map generated using the Brazilian families. The fraction of the total inheritance information extracted by the available marker data is indicated by the information content. To find evidence for loci that might affect both tuberculosis and leprosy (or subtype), linkage analyses were performed using appropriate combined family data sets. Simulations performed in ALLEGRO using observed allele frequencies for the 16 microsatellite markers (10-18 alleles; average heterozygosity 0.63) demonstrated that the 92 tuberculosis families had 98-100% power to detect linkage up to a critical value (Z lr ¼4.27) equivalent to an allele sharing LOD score 43.95 (Po0.00001) for a recessive or dominant susceptibility gene with penetrances 5, 50 or 99%. Similarly, the 72 leprosy families had 94-100% power to detect linkage (LOD score 43.95; Po0.00001; 5, 50 or 99% penetrance for recessive gene; 50 and 99% penetrance for dominant gene) for a gene controlling susceptibility to leprosy per se, with reduced power (48%) at low (5%) penetrance for a dominant gene. For leprosy subtypes, the LL and TT families each had 98-100% power to detect linkage (LOD score 43.95; Po0.00001) for a recessive gene at 5, 50 or 99% penetrance, with reduced power to detect linkage up to a critical value (Z lr ¼3.27) equivalent to an allele sharing LOD score 43.00 (Po0.0001) of 92-99% for a dominant gene at 99% penetrance, 82-84% at 50% penetrance and 53-55% at 5% penetrance.
Allelic association testing
Family-based allelic association tests were performed using the TDT. 28 Since all case-parent trios in the families were used in the analysis, we corrected for clustering at the nuclear family level and nonindependence between sibs using a robust sandwich estimator for the variance and a Wald w 2 test. Only the tuberculosis families had sufficient numbers of parent/child trios to carry out allelic association testing: 92% power to detect an effect (odds ratio¼2; P¼0.05) for SNP with a variant allele frequency of 0.5; 79% power for SNP with a variant allele frequency of 0.15; o50% power for SNP with a variant allele frequency of p0.1. Only SNPs where the variant allele was at frequency X0.1 were included in the analyses (see Supplementary Information- Table 9 ). Allelic associations, and relative risk estimates, were obtained by creating a case/pseudo-control study where the cases comprise the genotypes of the affected offspring, and the controls are the one to three other genotypes (depending on whether phase is known or inferred) which the affected offspring might have received from the parents. 29 The relative risks were estimated using conditional logistic regression analysis, again employing robust variance estimates to control for pedigree clustering and a Wald w 2 test to indicate overall significance for allelic associations. A stepwise logisticregression procedure 29 was used to evaluate the relative importance of variants within and between candidate gene loci. Wald w 2 tests were used to compare models in which the main effects for both loci are modelled with one in which the main effects at the primary locus only are included. Robust TDT and case/pseudo-control statistical tests implemented within Stata were developed by Heather Cordell and David Clayton at the Cambridge Institute for Medical Research and are available at Electronic Database Information 9. Correction for multiple testing was carried out using a strict Bonferroni correction 30 multiplying by the number (49) of informative markers typed.
Linkage disequilibrium
Linkage disequilibrium between pairs of markers across 17q11-q21 was determined using Hedrick's definition of Lewontin's D 0 statistic. 63 Initially, haplotype phase in a set of unrelated individuals was determined using the PHASE program, 64 and linkage disequilibrium statistics were then calculated using HaploXT. 65 Both programs are available at gMap.net based at the Wellcome Trust Centre for Human Genetics, Oxford (Electronic Database Information 10).
